Autopsy report · NCT05788991

Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 8 months after it had already started.
Ran for about 1 year 1 month before it stopped.
151 participants enrolled.
Results were posted on the registry 2 years 2 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 4
Sponsor: Medinova AG
Sponsor type: Industry
Conditions: Bacterial Vaginosis; Vaginal Infection; Vaginal Diseases
Interventions: Dequalinium Chloride; Metronidazole Oral
Participants: 151
Sites: 14
Countries: Czechia, Poland, Slovakia

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.